SmartCells

Innovative insulin solutions for diabetes and advanced polymer-based dosing for comprehensive medical applications.

General Information
Company Name
SmartCells
Founded Year
2003
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Health Care
Funding Stage
Series D
Social Media

SmartCells - Company Profile

SmartCells, Inc. is a biotechnology company founded in 2003 with a focus on developing innovative solutions for diabetes and other medical applications. The company's flagship product, SmartInsulin, is a self-regulating injectable insulin formulation designed to improve diabetes management. In addition to diabetes, SmartCells' advanced polymer-based dosing technology has potential applications in addressing a variety of medical needs, including fertility, thyroid, and growth hormone deficiencies. The company also seeks to tackle challenges in treatment compliance and therapeutic window issues in areas such as oncology and drug-device combinations. SmartCells, Inc. received a significant $4.10M Series D investment on 16 June 2010, with funding contributed by notable investors including Beacon Angels, Boston Harbor Angels, Cherrystone Angel Group, Angel Healthcare Investors, and CVP Management. The company, headquartered in Beverly, Massachusetts, continues to demonstrate potential for growth and impact in the biotechnology and healthcare industries. With its focus on addressing critical medical needs and its track record of attracting investments from respected angel and venture capital groups, SmartCells, Inc. stands as a compelling player in the evolving landscape of medical innovation and treatments.

Taxonomy: insulin products, diabetes management, injectable formulation, polymer-based dosing, medical applications, fertility treatment, thyroid treatment, growth hormone deficiencies, oncology treatments, drug-device combinations, innovation, healthcare solutions, compliance management

Funding Rounds & Investors of SmartCells (10)

View All
Funding Stage Amount No. Investors Investors Date
Series D $4.10M 5 CVP Management 16 Jun 2010
Grant $850.86K 1 National Institute of Diabetes and Digestive and Kidney Diseases 01 Aug 2009
Debt Financing $1.12M - 29 Jul 2009
Grant $1.55M 1 National Institute of Diabetes and Digestive and Kidney Diseases 15 Sep 2008
Series C Unknown 1 01 May 2008

View All 10 Funding Rounds

Latest News of SmartCells

View All

No recent news or press coverage available for SmartCells.

Similar Companies to SmartCells

View All
Idun Pharmaceuticals - Similar company to SmartCells
Idun Pharmaceuticals Pioneering therapeutic solutions to control apoptosis and advance treatments for liver disease, CNS disorders, inflammation, and cancer.
OSWEGO WELLNESS, INC - Similar company to SmartCells
OSWEGO WELLNESS, INC Offering comprehensive support for addiction, anxiety, mood disorders, and more, helping you overcome life's challenges.
Kroff, Inc. - Similar company to SmartCells
Kroff, Inc. Safety. Service. Solutions.
Underwood Engineers, Inc. - Similar company to SmartCells
Underwood Engineers, Inc. We solve our clients' engineering challenges with a commitment to outstanding value, service, and quality results.
Aqua Science, Inc. - Similar company to SmartCells
Aqua Science, Inc. Leaders in industrial water treatment and program efficiency utilizing our customized and affordable solutions.